miR-182-5p Induced by STAT3 Activation Promotes Glioma Tumorigenesis
Open Access
- 14 July 2016
- journal article
- research article
- Published by American Association for Cancer Research (AACR) in Cancer Research
- Vol. 76 (14) , 4293-4304
Abstract
Malignant glioma is an often fatal type of cancer. Aberrant activation of STAT3 leads to glioma tumorigenesis. STAT3-induced transcription of protein-coding genes has been extensively studied; however, little is known about STAT3-regulated miRNA gene transcription in glioma tumorigenesis. In this study, we found that abnormal activation or decreased expression of STAT3 promotes or inhibits the expression of miR-182-5p, respectively. Bioinformatics analyses determined that tumor suppressor protocadherin-8 (PCDH8) is a candidate target gene of miR-182-5p. miR-182-5p negatively regulated PCDH8 expression by directly targeting its 3′-untranslated region. PCDH8 knockdown induced the proliferative and invasive capacities of glioma cells. Silencing of PCDH8 or miR-182-5p mimics could reverse the inhibitory effect of WP1066, a STAT3 inhibitor, or STAT3 knockdown in vitro and in vivo on glioma progression. Clinically, expression levels of PCDH8 were inversely correlated with those of p-STAT3 or miR-182-5p in glioblastoma tissues. These findings reveal that the STAT3/miR-182-5p/PCDH8 axis has a critical role in glioma tumorigenesis and that targeting the axis may provide a new therapeutic approach for human glioma. Cancer Res; 76(14); 4293–304. ©2016 AACR.Keywords
All Related Versions
Funding Information
- National Cancer Institute (R01CA157933, R01CA182684, P50CA127001, and CA16672)
- National Natural Science Foundation (81502184)
This publication has 45 references indexed in Scilit:
- miR-182 integrates apoptosis, growth, and differentiation programs in glioblastomaGenes & Development, 2015
- Signaling-Mediated Regulation of MicroRNA ProcessingCancer Research, 2015
- microRNA-148a Is a Prognostic oncomiR That Targets MIG6 and BIM to Regulate EGFR and Apoptosis in GlioblastomaCancer Research, 2014
- Sustained activation of SMAD3/SMAD4 by FOXM1 promotes TGF-β–dependent cancer metastasisJournal of Clinical Investigation, 2014
- miR-124 Inhibits STAT3 Signaling to Enhance T Cell–Mediated Immune Clearance of GliomaCancer Research, 2013
- Stat3-mediated activation of microRNA-23a suppresses gluconeogenesis in hepatocellular carcinoma by down-regulating Glucose-6-phosphatase and peroxisome proliferator-activated receptor gamma, coactivator 1 alphaHepatology, 2012
- MicroRNAs, cancer and cancer stem cellsCancer Letters, 2011
- Genome-wide methylation analysis identifies epigenetically inactivated candidate tumour suppressor genes in renal cell carcinomaOncogene, 2010
- Genomewide DNA methylation analysis reveals novel targets for drug development in mantle cell lymphomaBlood, 2010
- Regulation of Metastases by Signal Transducer and Activator of Transcription 3 Signaling Pathway: Clinical ImplicationsClinical Cancer Research, 2007